See more : BoardWare Intelligence Technology Limited (1204.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Episurf Medical AB (publ) (EPIS-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Episurf Medical AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- Apogee Optocom Co., Ltd. (6426.TW) Income Statement Analysis – Financial Results
- Dynamic Precision Industry Corporation (8928.TWO) Income Statement Analysis – Financial Results
- Rainbow Rare Earths Limited (RBWRF) Income Statement Analysis – Financial Results
- CIP Merchant Capital Limited (CIP.L) Income Statement Analysis – Financial Results
- Voltabox AG (VOAXF) Income Statement Analysis – Financial Results
Episurf Medical AB (publ) (EPIS-B.ST)
About Episurf Medical AB (publ)
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Germany, the United Kingdom, and internationally. It offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; Epiguide, a surgical drill guide; and Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, it offers µiFidelity, an order management system, for placing and following up on order, uploading MRI scans, and consult patient's damage marking report. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.30M | 6.60M | 6.50M | 5.00M | 4.90M | 4.00M | 2.49M | 2.41M | 1.02M | 173.03K | 37.92K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 104.40M | 4.20M | 4.80M | 5.10M | 4.50M | 3.30M | 60.54M | -1.61M | 46.01M | 21.30M | 16.98M | 11.57M | 0.00 | 0.00 | 0.00 |
| Gross Profit | -94.10M | 2.40M | 1.70M | -100.00K | 400.00K | 700.00K | -58.05M | 4.01M | -44.99M | -21.13M | -16.94M | -11.57M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -913.59% | 36.36% | 26.15% | -2.00% | 8.16% | 17.50% | -2,330.92% | 166.72% | -4,426.53% | -12,211.91% | -44,690.69% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 2.70M | 11.60M | -6.90M | -4.10M | -5.50M | -9.70M | 3.71M | -1.61M | 466.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 1.20M | 1.10M | 0.00 | 0.00 | 485.36K | 325.00K | 455.50K | 222.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.57M | 7.57M | 3.79M | 0.00 |
| SG&A | -5.60M | -9.30M | -4.40M | 1.20M | 1.10M | -4.30M | 33.30M | 485.36K | 325.00K | 455.50K | 222.00K | 11.57M | 7.57M | 3.79M | 0.00 |
| Other Expenses | 0.00 | 79.40M | 78.00M | 66.20M | 73.60M | 67.90M | 63.64M | 32.96M | 23.44M | 12.13M | 5.26M | 4.74M | -2.59M | -1.02M | 540.53K |
| Operating Expenses | 2.70M | 79.40M | 71.10M | 63.30M | 69.20M | 58.20M | 63.64M | 64.11M | 45.02M | 33.43M | 23.32M | 16.30M | 4.98M | 2.78M | 540.53K |
| Cost & Expenses | 105.10M | 83.60M | 75.90M | 68.40M | 73.70M | 61.50M | 63.64M | 64.11M | 45.02M | 33.43M | 23.32M | 16.30M | 4.98M | 2.78M | 540.53K |
| Interest Income | 3.10M | 500.00K | 400.00K | 100.00K | 500.00K | 300.00K | 61.24K | 44.22K | 34.54K | 353.32K | 425.73K | 533.30K | 526.70K | 0.00 | 288.00 |
| Interest Expense | 900.00K | 700.00K | 200.00K | 700.00K | 800.00K | 700.00K | 2.96K | 2.94K | 687.00 | 6.48K | 2.75K | 441.00 | 3.73K | 0.00 | 0.00 |
| Depreciation & Amortization | 8.70M | 5.10M | 5.30M | 5.20M | 4.80M | 4.80M | 4.19M | 4.06M | 2.24M | 1.76M | 1.08M | 573.71K | 287.33K | 121.34K | 3.96K |
| EBITDA | -87.70M | -71.40M | -63.80M | -58.00M | -64.30M | -52.40M | -56.91M | -57.61M | -41.74M | -31.15M | -21.78M | -15.20M | -4.17M | -2.66M | -429.02K |
| EBITDA Ratio | -851.46% | -1,046.97% | -947.69% | -1,112.00% | -1,257.14% | -1,307.50% | -2,285.11% | -2,394.73% | -4,106.30% | -18,001.28% | -57,438.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -94.80M | -77.00M | -69.40M | -63.90M | -68.80M | -57.50M | -61.15M | -61.71M | -43.97M | -33.26M | -23.28M | -16.30M | -4.98M | -2.78M | -540.53K |
| Operating Income Ratio | -920.39% | -1,166.67% | -1,067.69% | -1,278.00% | -1,404.08% | -1,437.50% | -2,455.65% | -2,565.20% | -4,326.25% | -19,223.27% | -61,398.03% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 200.00K | -200.00K | 200.00K | 0.00 | -900.00K | -300.00K | 100.00K | 41.28K | 33.86K | 346.84K | 422.98K | 532.86K | 522.98K | -8.10K | 288.00 |
| Income Before Tax | -94.60M | -77.20M | -69.20M | -63.90M | -69.80M | -57.80M | -61.09M | -61.67M | -43.97M | -32.91M | -22.86M | -15.77M | -4.46M | -2.79M | -540.24K |
| Income Before Tax Ratio | -918.45% | -1,169.70% | -1,064.62% | -1,278.00% | -1,424.49% | -1,445.00% | -2,453.31% | -2,563.48% | -4,326.25% | -19,022.82% | -60,282.45% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 200.00K | 100.00K | 300.00K | 700.00K | 800.00K | 400.00K | -80.00 | 44.22K | 34.54K | 353.32K | -650.03K | 533.30K | 526.70K | 0.00 | 0.00 |
| Net Income | -94.80M | -77.30M | -69.50M | -64.60M | -70.60M | -57.80M | -61.09M | -61.67M | -43.97M | -32.91M | -22.86M | -15.77M | -4.46M | -2.79M | -540.24K |
| Net Income Ratio | -920.39% | -1,171.21% | -1,069.23% | -1,292.00% | -1,440.82% | -1,445.00% | -2,453.31% | -2,563.48% | -4,326.25% | -19,022.82% | -60,282.45% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.36 | -0.29 | -0.31 | -0.40 | -1.05 | -1.71 | -1.69 | -2.52 | -2.08 | -1.76 | -1.24 | -1.04 | -0.29 | -0.51 | -0.08 |
| EPS Diluted | -0.36 | -0.29 | -0.31 | -0.40 | -1.05 | -1.71 | -1.69 | -2.52 | -2.08 | -1.76 | -1.24 | -1.04 | -0.29 | -0.51 | -0.08 |
| Weighted Avg Shares Out | 267.00M | 266.63M | 226.59M | 162.08M | 67.34M | 33.74M | 36.08M | 24.50M | 21.15M | 18.71M | 18.44M | 15.17M | 15.17M | 5.49M | 6.73M |
| Weighted Avg Shares Out (Dil) | 267.00M | 266.63M | 226.59M | 162.08M | 67.34M | 33.74M | 36.08M | 24.50M | 21.15M | 18.71M | 18.44M | 15.17M | 15.17M | 5.49M | 6.73M |
Source: https://incomestatements.info
Category: Stock Reports